UniCAR02-T (IMP) With Targeting Module TM123 clinical trials

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

This study looks at the long-term effects of AvenCell's CAR-T cell treatments for blood cancers like lymphoma and leukemia, and also prostate cancer. It checks how safe and effective these treatments are over time for people who've already had them in past AvenCell trials.